Journal of Pharmaceutical Research Science & Technology [ ISSN: 2583-3332] https://openj.edwiserinternational.com/index.php/ijpp <p><strong>Journal of Pharmaceutical Research Science &amp; Technology</strong> is an open access peer reviewed journal. It is permanently archived in<a href="https://www.portico.org/publishers/edwiser/"> Portico</a> (United Kingdom) (through 2021).</p> <p><em><strong>ISSN: 2583-3332</strong></em></p> en-US editor.ijpp@edwiserperiodicals.com (Dr. MA Jahangir) editor.ijpp@edwiserperiodicals.com (Dr. S. S. Imam) Mon, 21 Oct 2024 06:15:15 +0000 OJS 3.3.0.6 http://blogs.law.harvard.edu/tech/rss 60 Observational study of twenty diabetic patients using the combination of "Diabetes free" and "Pancreas free", remedies from an Ivorian traditional healer https://openj.edwiserinternational.com/index.php/ijpp/article/view/144 <p>As a response to the adverse effects and high cost of conventional anti-diabetic drugs, traditional medicine seems to be an alternative for local populations. The objective of this study was to carry out a biological and clinical follow-up of diabetic patients using the ‘Diabete free’ and ‘Pancreas free’ combination remedies from an Ivorian traditional healer. A cross-sectional observational study was conducted on twenty (20) diabetic patients using the ‘Diabetes free’ and ‘Pancreas free’ combination remedies from August 2023 to February 2024. A questionnaire was filled in by volunteer patients. Weekly fasting capillary blood glucose levels were monitored. A clinical follow up was also used to identify adverse effects. Patients were 70% female and 30% male. 85% suffered from type 2 diabetes. Diabetes was a family trait in 70% of cases. Mean blood glucose at diagnosis was 2.20±0.77 g/l. ‘Diabetes Free’ and “Pancreas Free” are tablets made from medicinal plants. The dosage was one tablet (if blood glucose was between&nbsp; [1.26-1.60] g/l) or 2 tablets (if blood glucose was &gt; 1.60 g/l), to be repeated once daily. A weekly mean reduction in blood glucose of 0.07±0.03g/l was observed. The mean blood glucose at week 12 was 0.92±0.15g/l. Adverse effects were characterized by anorexia (55%), dizziness (60%) and digestive disorders (20%). ‘Diabetes Free’ and “Pancreas Free” could significantly help&nbsp; in reducing glycaemia, with adverse effects at beginning of treatment. However, further studies need to be done.</p> Effo KE*, Matto Y, Adehouni YA, Silue GA, Irié-N'Guessan AG and Kouakou-Siransy NG Copyright (c) 2024 Effo KE*, Matto Y, Adehouni YA, Silue GA, Irié-N'Guessan AG and Kouakou-Siransy NG https://creativecommons.org/licenses/by/4.0 https://openj.edwiserinternational.com/index.php/ijpp/article/view/144 Mon, 21 Oct 2024 00:00:00 +0000